13 Obesity Clinical Trials in Escondido, CA (2026)

Q: How do I join a clinical trial in Escondido?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Escondido research site will contact you.

Recruiting Obesity Studies in Escondido

NCT07654361Recruiting

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses ...

Escondido, CAPHASE33,600 participantsGasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

View Study Details

NCT07564414Recruiting

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe a...

Escondido, CAPHASE32,500 participantsNovo Nordisk A/S

View Study Details

NCT07784725Recruiting

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline a...

Escondido, CAPHASE32,500 participantsAstraZeneca

View Study Details

NCT07284875Recruiting

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

The primary objective of the study is to determine the effects of KAI-9531 subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight....

Escondido, CAPHASE32,340 participantsKailera

View Study Details

NCT07321886Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

The purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes. The study has two phases: a main phase and an ext...

Escondido, CAPHASE31,980 participantsEli Lilly and Company

View Study Details

NCT07284901Recruiting

Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on: * Percent change in body weight * Change in hemoglobin A1c (HbA1...

Escondido, CAPHASE31,156 participantsKailera

View Study Details

NCT07654374Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in participants living with overweight or obesity and T...

Escondido, CAPHASE31,100 participantsGasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

View Study Details

NCT07282600Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes. Pa...

Escondido, CAPHASE31,035 participantsEli Lilly and Company

View Study Details

NCT07595549Recruiting

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

The purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight. People in this study may also ha...

Escondido, CAPHASE3954 participantsPfizer

View Study Details

NCT07253285Recruiting

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

This study will look at how well CagriSema and cagrilintide help children and adolescents with excess body weight lose weight. The study has 2 parts: main and extension study. In the main study, parti...

Escondido, CAPHASE3460 participantsNovo Nordisk A/S

View Study Details

NCT07770841Recruiting

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body weight when compared to 'dummy' tablets (placebo). Res...

Escondido, CAPHASE3450 participantsNovo Nordisk A/S

View Study Details

NCT07509307Recruiting

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

This study is being done to look at the safety and effect of NNC0487-0111 in people with excess body weight and knee osteoarthritis when compared to placebo. There are 2 study treatments in this study...

Escondido, CAPHASE3400 participantsNovo Nordisk A/S

View Study Details

NCT07441252Recruiting

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and body weight in participants living with obesity or ov...

Escondido, CAPHASE2180 participantsAmgen

View Study Details

About Obesity Clinical Trials in Escondido

Obesity is a complex chronic disease involving an excessive amount of body fat that increases the risk of other diseases and health problems. It affects over 650 million adults worldwide. Treatment approaches include lifestyle modifications, medications (GLP-1 agonists), and bariatric surgery.

There are currently 13 obesity clinical trials recruiting participants in Escondido, CA. These studies are seeking a combined 18,655 participants. Research is being sponsored by Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics, Novo Nordisk A/S, AstraZeneca and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Obesity Clinical Trials in Escondido — FAQ

Are there obesity clinical trials in Escondido?

Yes, there are 13 obesity clinical trials currently recruiting in Escondido, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Escondido?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Escondido research site will contact you about next steps.

Are clinical trials in Escondido free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Escondido studies also compensate for your time and travel.

What obesity treatments are being tested?

The 13 active trials in Escondido are testing new therapies including novel drugs, biologics, and treatment approaches for obesity.

Data updated September 5, 2026 from ClinicalTrials.gov